The Children’s Center of Hamden (“TCCOH”) is providing notice of a recent data security incident that may have involved personal and/or protected health information. TCCOH takes...
Vivant Health is proud to announce a new strategic partnership with Pandia Health, a women-led, women-founded telemedicine provider committed to improving access to comprehensive women’s...
Talks highlight efficacy, durability, and safety of Nanoscope’s MCO (multi-characteristic opsin) optogenetic therapy platform Data forms the foundation for recent rolling Biologics License Application submission...
Builds on Three Consecutive Years of Top-Tier Performance in the New York State Department of Health Medicaid Quality Incentive Program Healthfirst, a leading not-for-profit health...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has asked Martin Makary, the Commissioner of the U.S. Food and Drug Administration (FDA) to review...
New Nature Medicine paper details how health inequities harm everyone, counters 4 fallacies of zero-sum health thinking, urges new collective action to advance healthcare reforms...
The 36-provider practice streamlines documentation and enhances patient care with Sunoh.ai integration. eClinicalWorks®, the largest ambulatory cloud EHR, today announced that South Lake Pediatrics, a prominent physician-owned...
Accreditation affirms Anthem’s commitment to advancing health equity and delivering high-quality, whole-person care to Californians. Anthem Blue Cross is pleased to announce its Commercial and...
Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization (MSO) platform, has entered into a definitive agreement to acquire Solaris...
Hixny has been awarded a contract by the Statewide Health Information Network for New York (SHIN-NY) to make patient encounter alerts available to healthcare providers and health...
Abcentra LLC, a clinical-stage biopharmaceutical company pioneering targeted therapies for cardiovascular inflammation, today announced the successful dosing of the first patient in its Phase 2b trial, FORTIFY,...
Company to Webcast Investor Event on August 30, 2025, at 1:00 p.m. EDT (7:00 pm CEST) Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company,...
TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment...
RCA Named Among America’s Best, Reflecting Commitment to Lifesaving Addiction Care Recovery Centers of America (RCA), a nationally recognized leader in evidence-based addiction treatment, is proud...
Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the world’s leading suppliers of pegfilgrastim...